Arcturus Therapeutics Holdings (ARCT) Revenue Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) Revenue Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 35.46% |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 7.82% |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | 19.04% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 64.03% |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 96.43% |
| 10 | Arcturus Therapeutics Holdings | 164.27 Mn | -47.10 Mn | - | -92.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.99% |
| Dec 31, 2025 | -68.39% |
| Sep 30, 2025 | -58.84% |
| Jun 30, 2025 | -43.24% |
| Mar 31, 2025 | -22.70% |
| Dec 31, 2024 | -26.22% |
| Sep 30, 2024 | -7.68% |
| Jun 30, 2024 | 373.99% |
| Mar 31, 2024 | -52.65% |
| Dec 31, 2023 | -80.75% |
| Sep 30, 2023 | 237.65% |
| Jun 30, 2023 | -61.17% |
| Mar 31, 2023 | 1,430.99% |
| Dec 31, 2022 | 2,666.53% |
| Sep 30, 2022 | 448.58% |
| Jun 30, 2022 | 1,253.97% |
| Mar 31, 2022 | 146.54% |
| Dec 31, 2021 | 158.89% |
| Sep 30, 2021 | 4.46% |
| Jun 30, 2021 | -13.82% |